DO
BIIB icon

denkapparat Operations’s Biogen BIIB Stock Holding History

denkapparat Operations’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.16M Hold
6,338
– – 0.48% 58
2025
Q4 		$1.12M Hold
6,338
– – 0.61% 32
2025
Q3 		$888K Buy
6,338
+2,098
+49% +$284K 0.57% 46
2025
Q2 		$533K Buy
4,240
+1,000
+31% +$125K 0.43% 85
2025
Q1 		$443K Buy
3,240
+1,620
+100% +$232K 0.47% 86
2024
Q4 		$248K Buy
+1,620
New +$273K 0.37% 119

Other funds holding BIIB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

denkapparat Operations's BIIB Position: Q1 2026 in Review

denkapparat Operations held its Biogen (BIIB) position steady in Q1 2026 at 6,338 shares worth $1.16M. The position accounts for 0.48% of the portfolio, ranked #58.

denkapparat Operations first reported a position in BIIB in Q4 2024 and has held it in 6 quarters since. 1,002 funds tracked by Wall St. Rank hold BIIB as of Q1 2026.

  • denkapparat Operations held 6,338 shares of Biogen worth $1.16M as of Q1 2026.
  • denkapparat Operations left its Biogen share count unchanged in Q1 2026.
  • Biogen made up 0.48% of denkapparat Operations's portfolio in Q1 2026, its #58 holding.
  • denkapparat Operations first reported a position in Biogen in Q4 2024 and has held it in 6 quarters since.
  • 1,002 funds tracked by Wall St. Rank held Biogen as of Q1 2026.

Based on denkapparat Operations's 13F filing for Q1 2026, filed 11 May 2026.